CheckMyRecalls

SUN PHARMACEUTICAL INDUSTRIES INC recalls Spironolactone Tablets

Published
13 Aug 2025
Units affected
11,328 bottles
Agency
FDA
Country
United States

The hazard

Presence of foreign substance: identified as aluminum.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01

Brand / company
SUN PHARMACEUTICAL INDUSTRIES INC
Codes / lots
Lot # P3314, Exp 11/30/2026
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 13 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.